Hemophagocytic Lymphohistiocytosis: An Underrecognized Complication of Pediatric Crimean‐Congo Hemorrhagic Fever
Pediatrics International · 2026
DOI: 10.1111/ped.70575 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatrics International, 2026. Verfasst von Kubra Aykac und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Hemorrhagic Fever, Crimean. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Aim
Secondary hemophagocytic lymphohistiocytosis (sHLH) is a potentially life‐threatening hyperinflammatory complication of Crimean‐Congo hemorrhagic fever (CCHF), yet pediatric data remain limited. This study aimed to characterize the clinical phenotype of pediatric CCHF‐associated sHLH and to identify early clinical features associated with sHLH development.
Methods
PCR‐confirmed pediatric CCHF cases from four tertiary centers in Türkiye (2018–2025) were retrospectively analyzed, and clinical characteristics, laboratory findings, treatment, and outcomes were compared between children with and without sHLH.
Results
Of 79 patients, 27 (34.2%) fulfilled the diagnostic criteria for sHLH. Compared with children without sHLH, these patients more frequently presented with hemorrhagic findings (44.4% vs. 11.5%, p = 0.002), diarrhea (37.0% vs. 7.7%, p = 0.004), and bradycardia (25.9% vs. 1.9%, p = 0.002), and had lower platelet and fibrinogen and higher ferritin, AST, ALT, and LDH concentrations at diagnosis. On multivariable analysis, bradycardia (OR 11.1, 95% CI 1.7–126.3), hemorrhagic findings (OR 7.1, 95% CI 2.1–26.5), and diarrhea (OR 6.4, 95% CI 1.6–29.0) remained independent predictors; hemorrhagic findings and diarrhea preceded the sHLH diagnosis, whereas bradycardia was identified concurrently. Ferritin and aPTT worsened progressively only in children with sHLH, whereas platelet count declined in both groups. Despite more frequent immunomodulatory therapy and transfusion, no deaths occurred.
Conclusions
Secondary HLH should be actively considered in pediatric CCHF, particularly with hemorrhagic findings, diarrhea, or bradycardia preceding full laboratory evolution to facilitate earlier diagnosis and timely therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
- Department of Pediatric Infectious Diseases, Sivas Numune Hospital, Sivas, Türkiye.
- Department of Pediatric Infectious Disease, Erzurum City Hospital, Erzurum, Türkiye.
- Department of Pediatrics, Hitit University Erol Olçok Training and Research Hospital, Çorum, Türkiye.
- Hacettepe University School of Medicine, Ankara, Türkiye.
- Department of Pediatric Hematology and Oncology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
ORCID-Profile: Kubra Aykac, Ozlem Cakici, Aylin Irmak Kuruc, Canan Ozlu, Pınar Koc, Bera Enes Seyrek, Tekin Aksu, Hanife Avci, Ali Bulent Cengiz, Yasemin Ozsurekci
Zitieren
APA
Aykac, K., Cakici, O., Kuruc, A. I., Ozlu, C., Koc, P., Seyrek, B. E., Aksu, T., Aytac, S., Avci, H., Cengiz, A. B., & Ozsurekci, Y. (2026). Hemophagocytic Lymphohistiocytosis: An Underrecognized Complication of Pediatric Crimean‐Congo Hemorrhagic Fever. Pediatrics International. https://doi.org/10.1111/ped.70575
Vancouver
Aykac K, Cakici O, Kuruc AI, Ozlu C, Koc P, Seyrek BE, et al. Hemophagocytic Lymphohistiocytosis: An Underrecognized Complication of Pediatric Crimean‐Congo Hemorrhagic Fever. Pediatrics International. 2026. doi:10.1111/ped.70575
BibTeX
@article{Aykac2026,
author = {Aykac, Kubra and Cakici, Ozlem and Kuruc, Aylin Irmak and Ozlu, Canan and Koc, Pınar and Seyrek, Bera Enes and Aksu, Tekin and Aytac, Selin and Avci, Hanife and Cengiz, Ali Bulent and Ozsurekci, Yasemin},
title = {Hemophagocytic Lymphohistiocytosis: An Underrecognized Complication of Pediatric Crimean‐Congo Hemorrhagic Fever},
journal = {Pediatrics International},
year = {2026},
doi = {10.1111/ped.70575}
}
EUVIMED